Levofloxacino Teva (Levofloxacin)

Levofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes that are essential for DNA replication and transcription. This inhibition prevents bacterial DNA from unwinding and rewinding, leading to a halt in bacterial cell division and ultimately bacterial cell death.

The dosage of Levofloxacino Teva is determined by the prescribing healthcare professional based on the specific infection, patient age, weight, renal function, and other clinical factors. No fixed dose is provided here; the prescriber will set the appropriate regimen.

Safety data for levofloxacin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss individual risk factors and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details, and any necessary import documentation.

Levofloxacino Teva belongs to the fluoroquinolone class, offering broad‑spectrum activity against many Gram‑negative and Gram‑positive bacteria. Compared with macrolides or beta‑lactams, fluoroquinolones often achieve higher tissue penetration and a rapid bactericidal effect, but they carry specific safety considerations such as tendon toxicity and QT prolongation.

Levofloxacino Teva should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Levofloxacino Teva is administered orally, usually as a tablet taken with a full glass of water. It can be taken with or without food, but if antacids containing aluminum or magnesium are used, they should be spaced at least two hours apart to avoid reduced absorption.

The most serious adverse events include tendon rupture or tendinitis, especially in the Achilles tendon, QT interval prolongation that may lead to arrhythmias, severe allergic reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis. Patients should be instructed to seek immediate medical attention if they experience any of these symptoms.

Levofloxacino Teva should be avoided in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, patients with certain cardiac conditions that predispose to QT prolongation, and in pregnant or breastfeeding women unless the benefit clearly outweighs the risk.